190 related articles for article (PubMed ID: 30502484)
1. Cartilage Oligomeric Matrix Protein initiates cancer stem cells through activation of Jagged1-Notch3 signaling.
Papadakos KS; Bartoschek M; Rodriguez C; Gialeli C; Jin SB; Lendahl U; Pietras K; Blom AM
Matrix Biol; 2019 Aug; 81():107-121. PubMed ID: 30502484
[TBL] [Abstract][Full Text] [Related]
2. Stromal cartilage oligomeric matrix protein as a tumorigenic driver in ovarian cancer via Notch3 signaling and epithelial-to-mesenchymal transition.
Gorji-Bahri G; Krishna BM; Hagerling C; Orimo A; Jirström K; Papadakos KS; Blom AM
J Transl Med; 2024 Apr; 22(1):351. PubMed ID: 38615020
[TBL] [Abstract][Full Text] [Related]
3. Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer.
Englund E; Bartoschek M; Reitsma B; Jacobsson L; Escudero-Esparza A; Orimo A; Leandersson K; Hagerling C; Aspberg A; Storm P; Okroj M; Mulder H; Jirström K; Pietras K; Blom AM
Oncogene; 2016 Oct; 35(43):5585-5596. PubMed ID: 27065333
[TBL] [Abstract][Full Text] [Related]
4. Nidogen-2 Maintains the Contractile Phenotype of Vascular Smooth Muscle Cells and Prevents Neointima Formation via Bridging Jagged1-Notch3 Signaling.
Mao C; Ma Z; Jia Y; Li W; Xie N; Zhao G; Ma B; Yu F; Sun J; Zhou Y; Cui Q; Fu Y; Kong W
Circulation; 2021 Oct; 144(15):1244-1261. PubMed ID: 34315224
[TBL] [Abstract][Full Text] [Related]
5. NOTCH3 expression is linked to breast cancer seeding and distant metastasis.
Leontovich AA; Jalalirad M; Salisbury JL; Mills L; Haddox C; Schroeder M; Tuma A; Guicciardi ME; Zammataro L; Gambino MW; Amato A; Di Leonardo A; McCubrey J; Lange CA; Liu M; Haddad T; Goetz M; Boughey J; Sarkaria J; Wang L; Ingle JN; Galanis E; D'Assoro AB
Breast Cancer Res; 2018 Sep; 20(1):105. PubMed ID: 30180881
[TBL] [Abstract][Full Text] [Related]
6. Expression of Jagged1/Notch3 Signaling Pathway and their Relationship with the Tumor Angiogenesis in TNBC.
Xue S; He L; Zhang X; Zhou J; Li F; Wang X
Arch Med Res; 2017 Feb; 48(2):169-179. PubMed ID: 28625320
[TBL] [Abstract][Full Text] [Related]
7. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
8. Cartilage oligomeric matrix protein is a novel notch ligand driving embryonic stem cell differentiation towards the smooth muscle lineage.
Ma B; Yao F; Xie N; Mao C; Liu F; Gong Z; Zhao G; Liu Z; Cai Z; Yu F; Dai R; Chen Z; Wang L; Xu Q; Kong W; Fu Y
J Mol Cell Cardiol; 2018 Aug; 121():69-80. PubMed ID: 29981303
[TBL] [Abstract][Full Text] [Related]
9. Immobilization of Jagged1 Enhances Vascular Smooth Muscle Cells Maturation by Activating the Notch Pathway.
Zohorsky K; Lin S; Mequanint K
Cells; 2021 Aug; 10(8):. PubMed ID: 34440858
[TBL] [Abstract][Full Text] [Related]
10. LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells.
Yue Z; Yuan Z; Zeng L; Wang Y; Lai L; Li J; Sun P; Xue X; Qi J; Yang Z; Zheng Y; Fang Y; Li D; Siwko S; Li Y; Luo J; Liu M
FASEB J; 2018 May; 32(5):2422-2437. PubMed ID: 29269400
[TBL] [Abstract][Full Text] [Related]
11. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K
J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922
[TBL] [Abstract][Full Text] [Related]
12. Constitutive NOTCH3 Signaling Promotes the Growth of Basal Breast Cancers.
Choy L; Hagenbeek TJ; Solon M; French D; Finkle D; Shelton A; Venook R; Brauer MJ; Siebel CW
Cancer Res; 2017 Mar; 77(6):1439-1452. PubMed ID: 28108512
[TBL] [Abstract][Full Text] [Related]
13. Cartilage oligomeric matrix protein is a prognostic factor and biomarker of colon cancer and promotes cell proliferation by activating the Akt pathway.
Liu TT; Liu XS; Zhang M; Liu XN; Zhu FX; Zhu FM; Ouyang SW; Li SB; Song CL; Sun HM; Lu S; Zhang Y; Lin J; Tang HM; Peng ZH
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1049-1063. PubMed ID: 29560517
[TBL] [Abstract][Full Text] [Related]
14. Stromal PTEN inhibits the expansion of mammary epithelial stem cells through Jagged-1.
Sizemore GM; Balakrishnan S; Hammer AM; Thies KA; Trimboli AJ; Wallace JA; Sizemore ST; Kladney RD; Woelke SA; Yu L; Fernandez SA; Chakravarti A; Leone G; Ostrowski MC
Oncogene; 2017 Apr; 36(16):2297-2308. PubMed ID: 27797378
[TBL] [Abstract][Full Text] [Related]
15. Notch3 inhibits cell proliferation and tumorigenesis and predicts better prognosis in breast cancer through transactivating PTEN.
Zhang YQ; Liang YK; Wu Y; Chen M; Chen WL; Li RH; Zeng YZ; Huang WH; Wu JD; Zeng D; Gao WL; Chen CF; Lin HY; Yang RQ; Zhu JW; Liu WL; Bai JW; Wei M; Wei XL; Zhang GJ
Cell Death Dis; 2021 May; 12(6):502. PubMed ID: 34006834
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Subcellular Notch2, Notch3 and Jagged1 Localization Patterns in Early Triple-negative Breast Cancer.
Strati TM; Kotoula V; Kostopoulos I; Manousou K; Papadimitriou C; Lazaridis G; Lakis S; Pentheroudakis G; Pectasides D; Pazarli E; Christodoulou C; Razis E; Pavlakis K; Magkou C; Chrisafi S; Aravantinos G; Bafaloukos D; Papakostas P; Gogas H; Kalogeras KT; Fountzilas G
Anticancer Res; 2017 May; 37(5):2323-2334. PubMed ID: 28476798
[TBL] [Abstract][Full Text] [Related]
17. Notch3/Jagged1 circuitry reinforces notch signaling and sustains T-ALL.
Pelullo M; Quaranta R; Talora C; Checquolo S; Cialfi S; Felli MP; te Kronnie G; Borga C; Besharat ZM; Palermo R; Di Marcotullio L; Capobianco AJ; Gulino A; Screpanti I; Bellavia D
Neoplasia; 2014 Dec; 16(12):1007-17. PubMed ID: 25499214
[TBL] [Abstract][Full Text] [Related]
18. MiR-571 affects the development and progression of liver fibrosis by regulating the Notch3 pathway.
Cong S; Liu Y; Li Y; Chen Y; Chen R; Zhang B; Yu L; Hu Y; Zhao X; Mu M; Cheng M; Huang Z
Sci Rep; 2021 Nov; 11(1):21854. PubMed ID: 34750395
[TBL] [Abstract][Full Text] [Related]
19. IL6 blockade potentiates the anti-tumor effects of γ-secretase inhibitors in Notch3-expressing breast cancer.
Wang D; Xu J; Liu B; He X; Zhou L; Hu X; Qiao F; Zhang A; Xu X; Zhang H; Wicha MS; Zhang L; Shao ZM; Liu S
Cell Death Differ; 2018 Feb; 25(2):330-339. PubMed ID: 29027990
[TBL] [Abstract][Full Text] [Related]
20. Notch3 Maintains Luminal Phenotype and Suppresses Tumorigenesis and Metastasis of Breast Cancer via Trans-Activating Estrogen Receptor-α.
Dou XW; Liang YK; Lin HY; Wei XL; Zhang YQ; Bai JW; Chen CF; Chen M; Du CW; Li YC; Tian J; Man K; Zhang GJ
Theranostics; 2017; 7(16):4041-4056. PubMed ID: 29109797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
